# Boston Scientific

Source: https://onco.cc/companies/boston-scientific/  
OnCo record `boston-scientific` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Medical device giant whose TheraSphere glass microspheres deliver yttrium-90 radioembolisation in liver cancer.

## Summary

Boston Scientific, based in Marlborough, Massachusetts, and listed as BSX, is the medical device company whose TheraSphere glass microspheres deliver yttrium-90 radioembolisation in liver cancer. TheraSphere has held FDA approval for hepatocellular carcinoma since 2021, was studied in the EPOCH trial in colorectal liver metastases, which was positive for progression-free survival, and is being tested in combination with immunotherapy, and the company also sells drug-eluting embolic beads and other interventional oncology devices. OnCo links it to hepatocellular carcinoma and colorectal cancer and to the radioembolisation and transarterial chemoembolisation technology records. Whether device-based liver-directed therapy keeps its role as systemic options improve is the open question. The technology pages carry the trial detail.

## Fields

- Kind: Company
- Last checked: 2026-09-07
- HQ: Marlborough, MA
- Type: devices
- Website: https://www.bostonscientific.com
- Ticker: BSX

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Boston_Scientific
- Official website: https://www.bostonscientific.com

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- fronts: [Radiation Therapy](https://onco.cc/fronts/radiation/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Cryoablation systems](https://onco.cc/technologies/cryoablation-systems/), [Endoscopic ultrasound and EBUS systems](https://onco.cc/technologies/endoscopic-ultrasound-systems/), [Radioembolisation (TARE / SIRT, yttrium-90)](https://onco.cc/technologies/radioembolisation-tare/), [Thermal ablation (RFA, microwave, cryo)](https://onco.cc/technologies/thermal-ablation/), [Transarterial chemoembolisation (TACE)](https://onco.cc/technologies/tace/)
- trials: [TheraSphere With Durvalumab and Tremelimumab for HCC](https://onco.cc/trials/nct05063565/)
- roadmaps: [Devices and physical therapies roadmap: heat and light → electric fields and focused sound → drug-releasing implants](https://onco.cc/roadmaps/devices-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/boston-scientific.json